Skip to main content
Clinical Trials/NL-OMON53711
NL-OMON53711RecruitingNot Applicable

The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration - POPular PET TAVI

Sint Antonius Ziekenhuis0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • o Successful TAVI with Sapien or CoreValve Evolut prosthesis about five years
  • o Able to undergo hybrid 18F-NaF PET-CT scan and transthoracic echocardiography
  • o Written informed consent

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • o Temporary or chronic oral anticoagulation use after TAVI
  • o Known severe renal insufficiency
  • o History of iodine contrast allergy
  • o Known severe paravalvular regurgitation
  • o History of valve-in-valve procedure
  • o History of aortic valve re-intervention (including percutaneous paravalvular
  • leak closure)

Investigators

Similar Trials